ORIGINAL RESEARCH article
Front. Endocrinol.
Sec. Molecular and Structural Endocrinology
Volume 16 - 2025 | doi: 10.3389/fendo.2025.1600623
This article is part of the Research TopicCommunity Series in : The Role of Vitamin D as an Immunomodulator - Volume IIView all 14 articles
Evaluation of Vitamin D Status, Vitamin D Receptor Expression, and Innate Immune Mediators in COVID-19
Provisionally accepted- 1Department of Medical Laboratory Technology, Faculty of Health Sciences, Beirut Arab University, Beirut, Lebanon
- 2Laboratory of Biological Chemistry Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece
- 3Alfaisal University, Riyadh, Saudi Arabia
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The Coronavirus disease 2019 (COVID-19) pandemic underscored the importance of identifying host factors that influence susceptibility to infection.Vitamin D signaling, mediated via its receptor (VDR-1), along with innate immune mediators such as antimicrobial peptides (e.g., DEFA1-3) and inflammatory chemokines (e.g., CCL20), plays a critical role in antiviral defense. This study aimed to determine how serum vitamin D status and gene expression of VDR-1, DEFA1-3, and CCL20 associate with COVID-19 risk in a Lebanese cohort. Methods: This prospective observational study assessed serum vitamin D concentrations and nasopharyngeal gene expression in Lebanese participants tested for SARS-CoV-2 between January and March 2024. We enrolled 264 patients undergoing RT-qPCR (targeting ORF1, N, and E genes) and quantified serum 25-hydroxyvitamin D [25(OH)D]. In a subset of 70 individuals stratified by COVID-19 status, we measured VDR-1, DEFA1-3, CCL20, and GAPDH expression by RT-qPCR. Multiple logistic regression and Pearson correlation analyses were performed. Results: Serum vitamin D levels and CCL20 expression were not significantly associated with COVID-19 status. Elevated VDR-1 expression in nasopharyngeal tissue correlated with lower COVID-19 risk (OR = 0.40, p = 0.05) and inversely with 25(OH)D levels (r = -0.61, p = 0.04).Higher DEFA1-3 expression reduced COVID-19 risk by 81.6% (OR = 0.184, p = 0.012).Among COVID-19 negatives, VDR-1 correlated with CCL20 (r = 0.59, p < 0.01); among positives, VDR-1 correlated with DEFA1-3 (r = 0.45, p < 0.05).Our findings reveal a complex interplay between systemic vitamin D status, local VDR-1 expression, and innate inflammatory mediators in COVID-19. They support a model in which both micronutrient levels and tissue-specific vitamin D signaling modulate host susceptibility and disease severity.
Keywords: COVID-19, Vitamin D, VDR-1, DEFA1-3, CCL20, innate immunity, Inflammatory biomarkers
Received: 26 Mar 2025; Accepted: 29 Jul 2025.
Copyright: © 2025 Missilmani, Maarabouni, Salem-Sokhn, Karras, Fakhoury and El Shamieh. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Hana M.A. Fakhoury, Alfaisal University, Riyadh, Saudi Arabia
Said El Shamieh, Department of Medical Laboratory Technology, Faculty of Health Sciences, Beirut Arab University, Beirut, 11072809, Lebanon
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.